Furthermore, many studies, including ours, investigated and showed the clinical relevance of LOXL2 expression during the metastasis of breast [13], gastric [14], liver [15], esophageal [16], and pancreatic [17] cancers. This evidence concerns the gene LOXL2 and cancer.